Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Con-call Audio recording for the Investor call held on May 29, 2024.29-05-2024
29-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of ESOP29-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting29-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Results For The Period Ended March 31, 2024
Results for the period ended March 31, 202429-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31, 2024.24-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement - Rights Issue22-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors call to discuss audited financial results for the period ended March 31, 2024.21-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31, 2024.
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2024.21-05-2024
Solara Active Pharma meets USFDA's inspection at its Visakhapatnam facility
The Visakhapatnam facility is a green field project spread over 40 acres and has facilities for the manufacture of Ibuprofen API20-05-2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached press release issued by the Company titled: ''''Solara Visakhapatnam facility completes USFDA Inspection with Zero 483 inspectional observations.20-05-2024